| Primary |
| Infective Exacerbation Of Bronchiectasis |
18.8% |
| Myocardial Ischaemia |
18.8% |
| Antiplatelet Therapy |
12.5% |
| Ischaemic Heart Disease Prophylaxis |
12.5% |
| Atrial Fibrillation |
6.3% |
| Bronchiectasis |
6.3% |
| Headache |
6.3% |
| Myocardial Infarct Prophylaxis |
6.3% |
| Pain Relief |
6.3% |
| Passed Out |
6.3% |
|
| Blindness Transient |
12.5% |
| Melaena |
12.5% |
| Off Label Use |
12.5% |
| Rash |
12.5% |
| Rhabdomyolysis |
12.5% |
| Therapeutic Response Unexpected |
12.5% |
| Vomiting |
12.5% |
| Weight Decreased |
12.5% |
|
| Secondary |
| Product Used For Unknown Indication |
35.6% |
| Pain In Jaw |
16.1% |
| Chest Pain |
12.1% |
| Drug Use For Unknown Indication |
6.7% |
| Blood Pressure |
4.7% |
| Sinus Headache |
4.0% |
| Atrial Fibrillation |
2.7% |
| Back Pain |
2.0% |
| Hypercholesterolaemia |
2.0% |
| Infective Exacerbation Of Bronchiectasis |
2.0% |
| Myocardial Ischaemia |
2.0% |
| Transient Ischaemic Attack |
2.0% |
| Anxiety |
1.3% |
| Ischaemic Heart Disease Prophylaxis |
1.3% |
| Multiple Allergies |
1.3% |
| Ventricular Tachycardia |
1.3% |
| Ankle Swelling |
0.7% |
| Blood Cholesterol Abnormal |
0.7% |
| Blood Pressure High |
0.7% |
| Bronchiectasis |
0.7% |
|
| Myocardial Infarction |
28.6% |
| Vaginal Haemorrhage |
9.5% |
| Condition Aggravated |
4.8% |
| Drug Ineffective |
4.8% |
| Feeling Abnormal |
4.8% |
| Loss Of Consciousness |
4.8% |
| Memory Impairment |
4.8% |
| Perforated Ulcer |
4.8% |
| Pruritus Genital |
4.8% |
| Rash |
4.8% |
| Toxicity To Various Agents |
4.8% |
| Vision Blurred |
4.8% |
| Vomiting |
4.8% |
| Weight Decreased |
4.8% |
| Wrong Technique In Drug Usage Process |
4.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
40.8% |
| Pain |
8.4% |
| Hypertension |
8.1% |
| Diabetes Mellitus |
4.9% |
| Cardiac Disorder |
4.3% |
| Rheumatoid Arthritis |
3.0% |
| Gastrooesophageal Reflux Disease |
2.8% |
| Blood Cholesterol Increased |
2.7% |
| Headache |
2.7% |
| Hyperchlorhydria |
2.5% |
| Blood Pressure |
2.4% |
| Blood Pressure Abnormal |
2.4% |
| Arthritis |
2.1% |
| Atrial Fibrillation |
2.1% |
| Chronic Obstructive Pulmonary Disease |
2.1% |
| Multiple Sclerosis |
2.1% |
| Prophylaxis |
2.1% |
| Osteoporosis |
1.7% |
| Crohn's Disease |
1.6% |
| Depression |
1.6% |
|
| Drug Ineffective |
11.4% |
| Off Label Use |
10.0% |
| Underdose |
7.1% |
| Vomiting |
7.1% |
| Weight Increased |
7.1% |
| Overdose |
5.7% |
| Product Quality Issue |
5.7% |
| Vitamin D Deficiency |
5.7% |
| Injection Site Pain |
4.3% |
| Pain |
4.3% |
| Pain In Extremity |
4.3% |
| Urticaria |
4.3% |
| Chest Pain |
2.9% |
| Death |
2.9% |
| Diarrhoea |
2.9% |
| Hyperhidrosis |
2.9% |
| Incorrect Drug Administration Duration |
2.9% |
| Intervertebral Disc Protrusion |
2.9% |
| Myocardial Infarction |
2.9% |
| Nasopharyngitis |
2.9% |
|
| Interacting |
| Product Used For Unknown Indication |
72.2% |
| Atrial Fibrillation |
2.8% |
| Blood Cholesterol Increased |
2.8% |
| Cardiac Failure Congestive |
2.8% |
| Cerebrovascular Accident Prophylaxis |
2.8% |
| Constipation |
2.8% |
| Hypertension |
2.8% |
| Joint Swelling |
2.8% |
| Multiple Allergies |
2.8% |
| Thrombosis Prophylaxis |
2.8% |
| Weight Loss Diet |
2.8% |
|
| Loss Of Consciousness |
25.0% |
| Subdural Haemorrhage |
25.0% |
| Syncope |
25.0% |
| Weight Increased |
25.0% |
|
